LAS VEGAS — In this video, Ali Azizzadeh, MD, discusses the 3-year results of a study of a thoracic stent graft for treatment of patients with acute complicated type B aortic dissection. The study ...
Endospan, an Israel-based developer of solutions for the endovascular repair of aortic arch disease, announced that the FDA ...
Research suggests that over 120,000 patients suffer from aortic arch disease in the US and Europe annually, but only around ...
Aortic graft and stent-graft infections (AGSGIs) are a type of infection that can occur after open or endovascular aortic repair. These types of infection affect the synthetic material used to replace ...
New Indication Expands Labeled Uses for Valiant® Captivia® System in U.S.;Six-Month Results of RESCUE Trial Will Be Presented at VEITHsymposium The second leading cause of traumatic death after head ...
Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Thoracic Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 ...
An increasing number of patients with thoracic aortic aneurysms are being treated with a device called a stent graft, rather than open-chest surgery. The device is delivered with a cathether. Patients ...
Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the NEXUS (R) ...
The Gore study will investigate how an endovascular stent graft, delivered via catheter, may be used to line the dissected portion of the ascending aorta as a less-invasive alternative to open ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results